SCHEMBL965094

SCHEMBL965094

O=CC1COCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17131097 1.00
SCHEMBL13637530 1.00
Hydrochloric Acid SCHEMBL27397572 0.98
Trimethylammonium SCHEMBL28039770 0.92
Dimethylamine SCHEMBL27638727 0.92
SCHEMBL27494311 0.86
SCHEMBL29197949 0.79
SCHEMBL293363 0.76
SCHEMBL18531888 0.76
SCHEMBL159078 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3483164-B1 PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS FORMA THERAPEUTICS INC (US) 2020-03-04 EP claimed
CN-106008491-B A kind of preparation method of razaxaban 苏州汇和药业有限公司 2019-04-05 CN claimed
CN-109111435-A A kind of pyrrolidines sulfonyl-derivatives ROR gamma modulators and application thereof 南京柯菲平盛辉制药有限公司 2019-01-01 CN claimed
CN-109111418-A A kind of 2,3- dihydro -1H- indenes -4- sulfonamide ROR gamma modulators and application thereof 南京柯菲平盛辉制药有限公司 2019-01-01 CN claimed
CN-108884029-A L SD1 inhibitors 米拉蒂医疗股份有限公司 2018-11-23 CN claimed
CN-108690010-A The preparation process of razaxaban 苏州中联化学制药有限公司 2018-10-23 CN claimed
CN-108290846-A Acylated N- (1,2,5- oxadiazole -3- bases) -, N- (1,3,4- oxadiazole -2- bases) -, N- (tetrazolium -5- bases)-and N- (triazole -5- bases)-aryl carboxylic acid amides and its purposes as herbicide 拜耳作物科学股份公司 2018-07-17 CN claimed
CN-108250193-A The method that one kettle way prepares razaxaban 江苏中邦制药有限公司 2018-07-06 CN claimed
CN-108218845-A A kind of chroman -6- sulfonamide ROR gamma modulators and application thereof 南京柯菲平盛辉制药有限公司 2018-06-29 CN claimed
CN-108164519-A The synthetic method of razaxaban process contaminants 江苏悦兴医药技术有限公司 2018-06-15 CN claimed
CN-104487436-B Improved process for preparing rivaroxaban using intermediates 信谊实验室有限公司 2017-05-24 CN claimed
CN-106661049-A Substituted tetrahydropyridothienopyrimidines 拜耳制药股份公司 2017-05-10 CN claimed
CN-104447607-B preparation method of Aprepitant intermediate 瑞阳制药有限公司 2017-02-22 CN claimed
CN-101981035-A Triazolium salts as PAR1 inhibitors, their preparation and their use as medicaments SANOFI AVENTIS 2011-02-23 CN claimed
US-7867992-B2 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses AICURIS GMBH & CO. KG (DE) 2011-01-11 US claimed
US-20070293478-A1 Substituted quinolones BAYER HEALTHCARE AG (DE) 2007-12-20 US claimed
EP-1768973-B1 SUBSTITUTED QUINOLONES AICURIS GMBH & CO KG (DE) 2007-12-05 EP claimed
CN-1968922-A Factor XA inhibitors MILLENNIUM PHARM INC (US) 2007-05-23 CN claimed
EP-1768973-A1 SUBSTITUTED QUINOLONES AiCuris GmbH & Co. KG (DE) 2007-04-04 EP claimed
WO-2006008046-A1 SUBSTITUTED QUINOLONES AICURIS GMBH & CO. KG (DE) 2006-01-26 WO claimed